SELLAS Life Sciences Group, Inc. SLS
14.86 USD -3.09 (-17.21%)
Regular-session close
14.67 -0.19 -1.28%
Pre-market · Nov 20, 4:10 AM ET
14.23 Day range 16.54
1.39 52-week range 24.89
- YTD
- +294.16%
- 1 year
- +877.63%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -28.27M | -31.51M | -37.87M | -41.95M | -25.29M | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.70M | |
| -0.25 | -0.50 | -1.34 | -2.13 | -1.34 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 71.89M | 13.99M | 2.63M | 17.23M | 21.45M | |
| 78.34M | 19.43M | 6.22M | 20.94M | 26.27M | |
| 7.47M | 9.97M | 14.20M | 16.09M | 5.93M | |
| 1.00M | 1.00M | 906.00K | 945.00K | 808.00K | |
| 70.87M | 9.46M | -7.98M | 4.85M | 20.35M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -28.39M | -35.40M | -31.41M | -23.81M | -26.02M | |
| 86.30M | 46.76M | 22.32M | 24.08M | 12.07M | |
| 57.91M | 11.36M | -14.60M | -4.23M | -13.95M |
